This increasing CGM slope prior to the competition may be influenced by the individual’s anxiety-proneness as measured by the STAI-trait survey, duration of diabetes, diabetes management as measured by HbA1c, and the insulin dosing behavior as measured by the ICII (Table 3E). The gene discussed is INS; the disease is Anxiety.